AEGLE THERAPEUTICS CORP

Profile

Company Names

AEGLE THERAPEUTICS CORP

Addresses

400 TRADECENTER DRIVE, SUITE 5900, WOBURN, MA 01801

1951 NW 7TH AVENUE, SUITE 160, #152, MIAMI, FL 33136

Phone Numbers

781-918-8449
305-243-4589

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$6,955,695.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2025-12-30 
$455,695.00 
$700,000.00 
$244,305.00 
Debt 
1
2020-01-03 
$6,500,000.00 
$6,500,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EVANGELOS 
 
BADIAVAS 
DIRECTOR, EXECUTIVE OFFICER
AEGLE THERAPEUTICS CORP
ELONA 
 
BAUM 
DIRECTOR
ABILITECH MEDICAL, INC.   |  BIOECLIPSE THERAPEUTICS, INC.   |  AEGLE THERAPEUTICS CORP   |  ORIG3N, INC.   |  ENDOGENA THERAPEUTICS, INC.
SCOTT 
 
BRAUNSTEIN 
DIRECTOR
ZIOPHARM ONCOLOGY INC   |  BWBC I LLC   |  CONSTELLATION PHARMACEUTICALS INC   |  AEGLE THERAPEUTICS CORP
SHELLEY 
 
HARTMAN 
EXECUTIVE OFFICER, DIRECTOR
AEGLE THERAPEUTICS CORP
LEON 
 
MOULDER 
DIRECTOR
DIANTHUS THERAPEUTICS, INC.   |  VITTORIA BIOTHERAPEUTICS, INC.   |  AEGLE THERAPEUTICS CORP
LEON 
 
MOULDER, JR. 
DIRECTOR
AEGLE THERAPEUTICS CORP   |  TAMUROBIO INC.   |  DIANTHUS THERAPEUTICS, INC.   |  INTERIUS BIOTHERAPEUTICS, INC.
STEVE 
 
O-HARA 
DIRECTOR
SIMILITY, INC.   |  KAIROS AR, INC.   |  STELLAR CYBER INC.   |  SIMBA CHAIN, INC.   |  MIRRORTAB CORP.   |  AEGLE THERAPEUTICS CORP
ROBERT 
 
RYAN 
DIRECTOR
DILITHIUM NETWORKS INC   |  PATIENTKEEPER INC   |  SCIODERM, LLC   |  SCIODERM, INC.   |  RENOVION, INC.   |  ST. CHARLES SC HOLDINGS, LLC   |  HAUPPAUGE SC HOLDINGS, LLC   |  AEGLE THERAPEUTICS CORP   |  REGENT SURGICAL HEALTH TOPCO, L.P.   |  REGENT SURGICAL HEALTH INTERMEDIATE HOLDINGS, INC.   |  CAERULEUS FUND
DAVID 
 
SCHIMEL 
DIRECTOR
AEGLE THERAPEUTICS CORP   |  ENTELLIGENT INC.
MIKIO 
 
TANJI 
DIRECTOR
AEGLE THERAPEUTICS CORP
ROBERT 
 
WILLIAMSON, JR. 
EXECUTIVE OFFICER, DIRECTOR
AEGLE THERAPEUTICS CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-03-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-12-30 
2020-07-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-03 
2020-05-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-03 
2020-01-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-01-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#